India
NeoDx is a Bengaluru-based biotech startup founded in 2020 with the mission of providing precision diagnostics through reliable results and affordable solutions. The company specializes in designing, developing, and manufacturing in-vitro diagnostics (IVD) kits for diagnosing infectious diseases, cancer, and genetic disorders. Their focus is on delivering high-quality, accessible molecular testing products to labs, diagnostic centers, and public and private hospitals in India and international markets.
NeoDx operates in the biotechnology and manufacturing industries, aiming to address critical healthcare needs with innovative solutions. Despite not having a public record of their last investment or investors, the company's dedication to accessible and reliable diagnostics positions them as a promising venture for potential investors seeking to support impactful and socially relevant healthcare initiatives.
With its commitment to addressing global health challenges, NeoDx presents an intriguing opportunity for venture capital firms seeking to invest in groundbreaking biotech startups with the potential for significant market impact and social value.
